According to TipRanks.com, Strauss ‘ ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -9.8% and a 50.0% success rate. Strauss covers the Basic Materials sector, focusing on stocks such as Wacker Chemie AG, LANXESS, and Linde.
Qiagen has an analyst consensus of Hold, with a price target consensus of $56.90.
See today’s analyst top recommended stocks >>
Qiagen’s market cap is currently $12.09B and has a P/E ratio of 64.30. The company has a Price to Book ratio of -32.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.